Vascular Cognitive Impairment no Dementia Clinical Trial
Official title:
The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND:A Randomized, Double-blind,and Neuroimaging Study
Vascular cognitive impairment no dementia (VCIND) is very common among the aged and tends to progress to dementia, but there have been no proper large-scale intervention trials dedicated to it. VCIND caused by subcortical ischemic small vessel disease (hereinafter, subcortical VCIND) represents a relatively homogeneous disease process and is a suitable target for therapeutic trials investigating VCIND. Preclinical trials showed that Butylphthalide Soft Capsules is effective for cognitive impairment of vascular origin. In this randomized, double-blind, placebo-controlled trial, the investigators apply fMRI study the effects of Butylphthalide Soft Capsules in patients with VCIND.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02640716 -
Cog-VACCINE: Cognitive Training in Patients With Vascular Cognitive Impairment, no Dementia
|
N/A | |
| Completed |
NCT03306979 -
Memory and Antioxidants in Vascular Impairment Trial
|
Phase 2 |